79363339 - AAVEX

Information

  • Trademark
  • 79363339
  • Serial Number
    79363339
  • Filing Date
    December 14, 2022
    2 years ago
  • Transaction Date
    November 08, 2024
    a month ago
  • Status Date
    April 08, 2024
    9 months ago
  • Location Date
    April 08, 2024
    9 months ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    FLETCHER, TRACY
  • Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
4
Mark Identification
AAVEX
Case File Statements
  • GS0051: Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use
  • GS0011: Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes
  • GS0421: Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services
Case File Event Statements
  • 8/31/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/6/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/25/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/25/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/17/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/23/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/24/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/28/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/5/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/8/2024 - 9 months ago
    10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 4/8/2024 - 9 months ago
    11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 11/8/2024 - a month ago
    13 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/8/2024 - 9 months ago
    12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2